Health & Medicine
Scientists find drug that may help in fight against Duchenne muscular dystrophy
By By Kim Irwin | 18 Dec 2012
Surgeons implant brain ‘pacemaker’ in Alzheimer’s Disease in clinical trials to slow memory loss
17 Dec 2012
What we eat affects our genes
15 Dec 2012
Yale team identifies successful combination drug therapies for melanoma mutations
By By Helen Dodson | 14 Dec 2012
Heart cells beat in bioscaffold for babies: biocompatible patch heals infants with heart defects
14 Dec 2012
Got food allergies? Test your meal on the spot using a cell phone
By By Matthew Chin | 13 Dec 2012
Scientists discover how to heal osteoarthritis
13 Dec 2012
Combination therapy with experimental drug improves outlook for breast cancer patients
By By Shaun Mason | 11 Dec 2012
First US 'breathing lung' transplant could transform field of lung transplantation
By By Amy Albin | 10 Dec 2012
UCLA doctors remove man's heart, replace it with total artificial heart
By By Amy Albin | 08 Dec 2012
Are electronic cigarettes safe?
07 Dec 2012
Are e-cigaettes harmful to users? A number of voices, primarily from the political sphere, are warning of possible health risks, claiming that the long-term consequences cannot yet be foreseen
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
